Midostaurin in Advanced Systemic Mastocytosis

N Engl J Med. 2016 Jun 30;374(26):2605-7. doi: 10.1056/NEJMc1515403.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Mastocytosis, Systemic / drug therapy*
  • Multivariate Analysis
  • Staurosporine / adverse effects
  • Staurosporine / analogs & derivatives*
  • Staurosporine / therapeutic use
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Staurosporine
  • midostaurin